$150 M funding opportunities DoD breast cancer research

The Fiscal Year 2005 (FY05) Defense Appropriations Act provides $150 million to the Department of Defense Breast Cancer Research Program (BCRP). This program is administered by the US Army Medical Research and Materiel Command through the Office of the Congressionally Directed Medical Research Programs (CDMRP).

The FY05 BCRP Program Announcements for proposals in the following mechanisms are available and proposals may be submitted.
BCRP Funding Mechanisms Anticipated Proposal Submission
Date by 5:00 p.m. Eastern Time

Detailed descriptions of each mechanism, evaluation criteria, submission requirements, and deadlines are available in the FY05 BCRP Program Announcements.

Points of Contact: Gail Whitehead, Public Affairs Coordinator, 301-619-7783, gail.whitehead@det.amedd.amedd.army.mil
Richard Kenyon, Ph.D., BCRP Program Manager, 301-619-7071


Contact: Gail Whitehead
US Department of Defense Congressionally Directed Medical Research Programs

Page: 1

Related biology news :

1. Energy department selects 3 Bioenergy Research Centers for $375 million in federal funding
2. WPI professor to represent American Mathematical Society at exhibition on science funding
3. NSF funding to advance research on interplay between biology and society
4. Energy and Agriculture Departments provide $8.3 million in funding for biofuels research
5. International risk research strategy and funding needed for nanotech safety
6. San Diego stem cell consortium tops in state funding
7. Nanotech safety needs specific government risk research strategy and funding
8. Report outlines funding to conserve half of Massachusettss land
9. NIH funding renewed for VA study of alcohol and HIV/AIDS interactions
10. Pancreas bioengineering at the MUHC receives funding boost
11. 250,000 funding boost for research into eye disease

Post Your Comments:

(Date:8/21/2020)... ... August 18, 2020 , ... ... today announced that the U.S. Food and Drug Administration (FDA) has approved the ... SBI-101, for the treatment of severe COVID-19. Approval of this IND allows Sentien ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... Princeton, NJ, have entered into license agreements with Housey Pharma’s HMI subsidiary to ... Roche and J&J have annual Research and Development spending in excess of US ...
(Date:8/5/2020)... ... ... Regenative Labs has received approval from the Centers for Medicare & Medicaid ... Wharton’s jelly allografts to be assigned a Q code and be approved for application ... jelly allograft product to be recognized as a 361 HCT/P by CMS regulated under ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... SOUTH RIDING, Va. (PRWEB) , ... September 01, ... ... search firm for life sciences, biotechnology, and diagnostics companies, has announced the placement ... Technologies . Averill will be responsible for leading all financial operations and implementing ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... firm, is making available for free its new white paper – Simulated ... simulation testing into today’s biologics licensing application (BLA). In response, Modality Solutions ...
(Date:7/31/2020)... Ariz. (PRWEB) , ... July 29, 2020 , ... R3 ... joint injections for only $3950. With 50 million stem cells total, patients may choose ... stem cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, ...
(Date:7/31/2020)... ... ... eSource has long been touted as the solution to high data management ... reasons it did not take off as quickly as people initially expected, and where ... towards capturing data electronically for clinical trials and then repurposing it for downstream analysis, ...
Breaking Biology Technology:
Cached News: